Citadel Advisors’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-5,829
Closed -$32K – 15593
2022
Q3
$32K Sell
5,829
-2,925
-33% -$55.8K ﹤0.01% 11879
2022
Q2
$493K Buy
8,754
+5,017
+134% +$274K ﹤0.01% 8688
2022
Q1
$221K Buy
3,737
+14
+0.4% +$713 ﹤0.01% 11296
2021
Q4
$257K Sell
3,723
-1,826
-33% -$141K ﹤0.01% 11281
2021
Q3
$398K Buy
5,549
+3,240
+140% +$253K ﹤0.01% 10424
2021
Q2
$193K Buy
2,309
+666
+41% +$50.5K ﹤0.01% 12198
2021
Q1
$115K Buy
+1,643
New +$128K ﹤0.01% 12346
2020
Q2
– Sell
-306
Closed -$14K – 10652
2020
Q1
$14K Buy
+306
New +$14.4K ﹤0.01% 9373
2018
Q2
– Sell
-449
Closed -$36K – 9388
2018
Q1
$36K Buy
449
+126
+39% +$25.4K ﹤0.01% 8008
2017
Q4
$80K Buy
+323
New +$75.1K ﹤0.01% 7501

Other funds holding NTBL

Citadel Advisors's NTBL Position: Q1 2023 in Review

Citadel Advisors sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q1 2023, closing a stake of 3,666 shares — an estimated $15.4K sold.

Citadel Advisors first reported a position in NTBL in Q1 2017 and held it in 12 quarters. The position peaked at $303K in Q2 2021. 18 funds tracked by Wall St. Rank hold NTBL as of Q1 2023.

  • Citadel Advisors reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 3,666 Notable Labs, Ltd. Ordinary Shares shares in Q1 2023, an estimated $15.4K.
  • Citadel Advisors first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2017 and held it in 12 quarters.
  • Citadel Advisors's Notable Labs, Ltd. Ordinary Shares position peaked at $303K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.